FDA Adverse Event Injury Summary report: N

STRATA®

MDR report key: 14188622 · Received April 22, 2022

Report

Report Number
9612501-2022-00630
Event Type
Injury
Date Received
April 22, 2022
Date of Event
February 1, 2022
Report Date
April 22, 2022
Manufacturer
COVIDIEN LLC
Product Code
JXG
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

PATIENT INFORMATION WAS UNAVAILABLE FROM THE SITE. EVENT DATE IS THE ONLINE PUBLISHING DATE OF THE LITERATURE ARTICLE. DEVICE LOT NUMBER, OR SERIAL NUMBER, UNAVAILABLE. 510(K) IS DEPENDENT UPON THE DEVICE MODEL NUMBER AND THEREFORE, UNAVAILABLE. NO PARTS HAVE BEEN RECEIVED BY THE MANUFACTURER FOR EVALUATION. DEVICE MANUFACTURING DATE IS DEPENDENT ON LOT NUMBER/SERIAL NUMBER, THEREFORE, UNAVAILABLE. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

GORDILLOA, B.F., BENÍTEZ, M.A.P., LEÓNC, M.I.M., IGLESIAS, S. PERITONEAL SHUNTING IN PEDIATRIC PATIENTS AND THE ROLE OF IMAGING IN ITS ASSESSMENT. RADIOLOGY 2022 (64) 136-144. HTTPS://DOI.ORG/10.1016/J.RX.2022.02.001. ABSTRACT LUMBOPERITONEAL SHUNTING MAKES IT POSSIBLE TO REGULATE THE FLOW OF CEREBROSPINAL FLUID BY ESTABLISHING A CONNECTION BETWEEN THE CAL SAC AND THE PERITONEAL CAVITY. THE MAIN INDICATION FOR LUMBOPERITONEAL SHUNTING IN CHILDREN IS IDIOPATHIC INTRACRANIAL HYPERTENSION, BUT THE TECHNIQUE IS ALSO USEFUL IN THE TREATMENT OF POSTINFECTIOUS, POSTHEMORRHAGIC, AND NORMOTENSIVE HYDROCEPHALUS, AS WELL AS IN THE TREATMENT OF POSTSURGICAL PSEUDOMENINGOCELE OR LEAKAGE OF CEREBROSPINAL FLUID. REPORTABLE EVENTS: 2 PATIENT WITH OBSTRUCTION THAT NEEDED A REVISION SURGERY 1 PATIENT WHERE THE VALVE DISCONNECTED THAT NEEDED A MEDICAL TREATMENT 1 PATIENT WHERE THE VALVE DISCONNECTED THAT NEEDED A REVISION SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
742628 STRATA® SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS JXG COVIDIEN LLC UNKNOWN-S

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other